World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
49
Citations
8664
World Ranking
5991
National Ranking
505

Ralph Buchert publications per year

1996: 4 publications 1997: 0 publications 1998: 3 publications 1999: 10 publications 2000: 4 publications 2001: 12 publications 2002: 4 publications 2003: 4 publications 2004: 4 publications 2005: 4 publications 2006: 17 publications 2007: 5 publications 2008: 13 publications 2009: 8 publications 2010: 17 publications 2011: 12 publications 2012: 12 publications 2013: 16 publications 2014: 16 publications 2015: 27 publications 2016: 15 publications 2017: 17 publications 2018: 11 publications 2019: 28 publications 2020: 22 publications 2021: 16 publications 2022: 14 publications 2023: 20 publications 2024: 24 publications 2025: 14 publications
1996 2025

373 publications in total across all disciplines

Ralph Buchert publication distribution in Neuroscience in 2027

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2027. The highlighted bar marks where Ralph Buchert sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 307 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Ralph Buchert D-index placement in Neuroscience in 2027

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2027. The highlighted bar marks where Ralph Buchert sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 49 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Ralph Buchert is affiliated with Universität Hamburg in Germany and has a substantial record of research output primarily in the field of Medicine with a focus on Radiology, Nuclear Medicine and Imaging. Their work extends into the domains of Neurology, Psychiatry and Mental Health, Cognitive Neuroscience, and Cellular and Molecular Neuroscience.

The scientist's research encompasses various topics including Medical Imaging Techniques and Applications, Parkinson's Disease Mechanisms and Treatments, Advanced MRI Techniques and Applications, Dementia and Cognitive Impairment Research, Neurological Disorders and Treatments, Functional Brain Connectivity Studies, and Advanced Neuroimaging Techniques and Applications.

Ralph Buchert has contributed frequently to journals such as Nuklearmedizin - NuclearMedicine, European Journal of Nuclear Medicine and Molecular Imaging, Alzheimer's & Dementia, Journal of Alzheimer's Disease, and Clinical Nuclear Medicine. Their publications span a variety of significant venues in nuclear medicine and neurodegenerative disease fields.

Several recent papers reflect their research focus and collaboration network:

  • Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration, 2021, Alzheimer's Research & Therapy
  • Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients, 2020, Schizophrenia Bulletin
  • Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC, 2022, Alzheimer's & Dementia
  • Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Severity of Subjective Cognitive Complaints and Worries in Older Adults Are Associated With Cerebral Amyloid-β Load, 2021, Frontiers in Aging Neuroscience

The frequent co-authors associated with their work include Ivayla Apostolova, Susanne Klutmann, Catharina Lange, Franziska Mathies, and Stefan Teipel, indicating collaborative efforts in the fields related to neuroimaging and neurodegenerative disease research.

Best Publications

  • Ventral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decision making

    Lorenz Deserno;Lorenz Deserno;Lorenz Deserno;Quentin J. M. Huys;Rebecca Boehme;Ralph Buchert

  • Feasibility of 18F-Sodium Fluoride PET/CT for Imaging of Atherosclerotic Plaque

    Thorsten Derlin;Ulrich Richter;Peter Bannas;Philipp Begemann

  • Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.

    R. Thomasius;K. Petersen;R. Buchert;B. Andresen

  • Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease

    Frank Leypoldt;Ralph Buchert;Ingo Kleiter;Jörg Marienhagen

  • FDG PET in the diagnosis of hilar cholangiocarcinoma.

    A Fritscher-Ravens;K H Bohuslavizki;D C Broering;L Jenicke

  • Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective:

    R. Thomasius;P. Zapletalova;K. Petersen;R. Buchert

  • A Voxel-Based PET Investigation of the Long-Term Effects of “Ecstasy” Consumption on Brain Serotonin Transporters

    Ralph Buchert;Rainer Thomasius;Florian Wilke;Kay Petersen

  • [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism

    Sabine Hellwig;Florian Amtage;Annabelle Kreft;Ralph Buchert

  • Value of FDG PET in patients with fever of unknown origin.

    J Lorenzen;R Buchert;K H Bohuslavizki

  • Long-Term Effects of “Ecstasy” Use on Serotonin Transporters of the Brain Investigated by PET

    Ralph Buchert;Rainer Thomasius;Bruno Nebeling;Kay Petersen

  • PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.

    Gabriel Gonzalez-Escamilla;Catharina Lange;Stefan Teipel;Ralph Buchert

  • IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment

    H. Prüss;M. Höltje;N. Maier;A. Gomez

  • High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.

    Sarah Doss;Klaus-Peter Wandinger;Bradley T. Hyman;Jessica A. Panzer

  • Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons.

    Johannes Piepgras;Markus Höltje;Klaus Michel;Qin Li

  • Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours

    Winfried Brenner;Reinhard E. Friedrich;Karim A. Gawad;Christian Hagel

  • Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence

    Florian Schlagenhauf;Michael A. Rapp;Quentin J. M. Huys;Quentin J. M. Huys;Anne Beck

  • Ecstasy : long-term effects on the human central nervous system revealed by positron emission tomography

    Jost Obrocki;Ralph Buchert;Ole Väterlein;Rainer Thomasius

  • Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease

    Lars Frings;Sabine Hellwig;Timo S. Spehl;Tobias Bormann

  • Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer

    Ivayla Apostolova;Ingo G. Steffen;Ingo G. Steffen;Florian Wedel;Alexandr Lougovski

  • Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours

    Nils F. Schreiter;Winfried Brenner;Munenobu Nogami;Ralph Buchert

Frequent Co-Authors

Michel J. Grothe
Michel J. Grothe Institute of Biomedicine of Seville
Florian Schlagenhauf
Florian Schlagenhauf Charité - University Medicine Berlin
Jochen B. Fiebach
Jochen B. Fiebach Charité - University Medicine Berlin
Lorenz Deserno
Lorenz Deserno University of Wurzburg
Andreas Heinz
Andreas Heinz Charité - University Medicine Berlin
Oliver Peters
Oliver Peters German Center for Neurodegenerative Diseases
Cornelius Weiller
Cornelius Weiller University of Freiburg
Christoph A. Nienaber
Christoph A. Nienaber National Institutes of Health
Emrah Düzel
Emrah Düzel German Center for Neurodegenerative Diseases
Harald Hampel
Harald Hampel Eisai (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ralph Buchert

Trending Scientists

Recently Published Articles